Glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is common people with eating disorders, according to a research letter published online June 24 in JAMA ...
With over 30% of eating disorder patients utilizing GLP-1 medications, experts urge primary care clinicians to screen for disordered eating before prescribing.
In contrast, one research trial using GLP-1 drugs on obese research subjects did not show a benefit from GLP-1 in the ...
GLP-1s significantly reduce appetite, slow digestion and promote weight loss.
Even a chatbot trained on nutrition and fitness research that dispenses reasonable-sounding guidance can become a deadly ...
Please provide your email address to receive an email when new articles are posted on . Eating disorders primarily affect women and typically present early in life. Support should focus on a high ...
Apply evidence-based nutritional restoration protocols to the goals of inpatient hospitalization and evaluation of risks of refeeding syndrome in pediatric patients with eating disorders to formulate ...
4d
Young people from less-advantaged backgrounds are more likely to have an undiagnosed eating disorder
Eating disorders are often associated with teenage girls from socioeconomically advantaged families. However, a new study ...
People with anorexia nervosa have unusually high levels of a hormone called LEAP2 in their blood when they are in the acute ...
It’s Sunday night, and you’re lying in bed, you reach for your phone and scroll through social media in search of a little escape. An influencer pops up with a “what I eat in a day” post—the ...
A US study found that nearly 1 in 3 people with eating disorders had used GLP-1 drugs such as Ozempic, Wegovy or tirzepatide.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results